Evolution News and Research

RSS

Study finds reduction in pain favoring Mynx Vascular Closure Device to Angio-Seal Evolution Device

AccessClosure, Inc., the U.S. market segment leader in extravascular closure devices, announced today results from the first published study (Journal of NeuroInterventional Surgery) comparing the pain associated with deployment of different vascular closure devices (VCD) as the primary endpoint.

9 Mar 2011

UH conducts first ever pilot study to test heat therapy for treatment of PE

University Hospitals Case Medical Center is conducting the first ever pilot study to test a new procedure using "heat therapy" or local radiofrequency energy to treat premature ejaculation.

9 Mar 2011

Sanfilippo syndrome compromises blood-brain barrier, leads to brain damage

A study into the effects of Sanfilippo Syndrome type B (MPS III B) has found that the barrier responsible for protecting the brain from the entry of harmful blood-borne substances is structurally and functionally damaged by the devastating disease. University of South Florida researchers identified damage in specific brain structures involved in the pathology of MPS III B, one of four Sanfilippo syndromes, all of which are inherited diseases of metabolism.

9 Mar 2011

Scientists develop innovative device to efficiently identify CTCs in blood

Circulating tumor cells, which play a crucial role in cancer metastasis, have been known to science for more than 100 years, and researchers have long endeavored to track and capture them.

8 Mar 2011

New insight into coronary artery disease

Insight into the complex biological mechanisms that cause heart disease has taken a major step forward with the discovery of 13 new genes that increase the risk of coronary artery disease.

7 Mar 2011

Study examines link between voice pitch and perceived infidelity

When choosing a partner, women believe the lower the man's voice, the more likely he's going to cheat. Conversely, men think a woman with a higher voice is more likely to be unfaithful, researchers have found.

5 Mar 2011

American Express, TakePart announce final round of Members Project winners

American Express and TakePart announced today the final round of Members Project winners, chosen by the public through online voting. These five organizations will collectively receive $1 million in funding from American Express to advance their missions of serving communities around the country.

5 Mar 2011

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

Endo Pharmaceuticals announced that FORTESTA Gel – recently approved by the U.S. Food and Drug Administration for the treatment of low testosterone, or 'Low T' in adult males – is now available by prescription in pharmacies across the country.

3 Mar 2011

International consortium of researchers genetically characterise Spanish Fanconi anaemia patients

A consortium of thirty-two researchers worldwide, led by Dr Jordi Surrallés, professor of the Department of Genetics and Microbiology at Universitat Autònoma de Barcelona (UAB) and member of the Centre for Biomedical Network Research on Rare Diseases (CIBERER), genetically and clinically characterised almost all Spanish patients suffering from Franconi anaemia, a rare disease affecting one in every 500,000 persons and which is characterised by severe anaemia in children, congenital malformations and a high predisposition to cancer.

3 Mar 2011

IBM announces new Patient Empowerment System

Today IBM announced the next evolution of the patient portal, significantly expanding the types of information, alerts, recommendations and interactive coaching healthcare providers can offer to their patients online.

3 Mar 2011

Ipsen 2010 total revenues increase 5.2% to €1,170.3 million

In 2010, Group drug sales grew 5.1% year-on-year - at constant currency - exceeding the objective set a year ago of 3.0% to 5.0%, fuelled notably by the sales of Specialty Care products throughout all the geographical regions where the Group operates.

2 Mar 2011

Health Care REIT signs definitive agreement to acquire Genesis for $2.4 billion

Health Care REIT, Inc. announced that it has signed a definitive agreement to acquire substantially all of the real estate assets of privately-owned Genesis HealthCare, a leading provider of short-term post-acute, rehabilitation, assisted living and long-term care services, for a purchase price of $2.4 billion.

28 Feb 2011

Endo fourth quarter total revenues increase 31% to $511 million

Endo Pharmaceuticals today reported financial results for the fourth quarter 2010.

28 Feb 2011

First study to show link between AVPR1A gene variants with listening to music

Music is listened in all known cultures. Similarities between human and animal song have been detected: both contain a message, an intention that reflects innate emotional state that is interpreted correctly even among different species.

28 Feb 2011

New findings disclose mechanisms that control Rb2/p130 gene expression in lung cancer cells

Despite innumerable studies on lung cancer, many aspects of the disease have yet to be understood, including the role played by the retinoblastoma-related protein Rb2/p130 in the evolution of the disease.

27 Feb 2011

New study discloses mechanism controlling Rb2/p130 gene expression in lung cancer cells

25 Feb 2011

Symposium examines Bruesewitz vs. Wyeth Supreme Court case

A March 29 symposium at the New York Academy of Sciences, "Vaccines Under the Gun: Politics, Science, Media and the Law," will feature a presentation by Daniel J. Thomasch, JD, national lead trial counsel for Wyeth, who was involved in the case decided by the Supreme Court yesterday in which the justices rejected a lawsuit claiming injury from a Wyeth vaccine.

25 Feb 2011

Evolutionary changes may have influenced metabolism and increased risk of diabetes

Researchers at the University of California, San Diego School of Medicine and Rady Children's Hospital-San Diego say an evolutionary gene mutation that occurred in human millions of years ago and our subsequent inability to produce a specific kind of sugar molecule appears to make people more vulnerable to developing type 2 diabetes, especially if they're overweight.

25 Feb 2011

Research: Loss of CMAH's function may make humans more prone to obesity and diabetes

As if the recent prediction that half of all Americans will have diabetes or pre-diabetes by the year 2020 isn't alarming enough, a new genetic discovery published online in the FASEB Journal provides a disturbing explanation as to why: we took an evolutionary "wrong turn."

25 Feb 2011

PolyMedix completes PMX-30063 Phase 1 exposure-escalation clinical study to treat Staph infections

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, today announced the successful completion of a Phase 1 exposure-escalation clinical study with its synthetic defensin-mimetic antibiotic, PMX-30063.

24 Feb 2011

Evolution News and Research

Study finds reduction in pain favoring Mynx Vascular Closure Device to Angio-Seal Evolution Device

UH conducts first ever pilot study to test heat therapy for treatment of PE

Sanfilippo syndrome compromises blood-brain barrier, leads to brain damage

Scientists develop innovative device to efficiently identify CTCs in blood

New insight into coronary artery disease

Study examines link between voice pitch and perceived infidelity

American Express, TakePart announce final round of Members Project winners

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

International consortium of researchers genetically characterise Spanish Fanconi anaemia patients

IBM announces new Patient Empowerment System

Ipsen 2010 total revenues increase 5.2% to €1,170.3 million

Health Care REIT signs definitive agreement to acquire Genesis for $2.4 billion

Endo fourth quarter total revenues increase 31% to $511 million

First study to show link between AVPR1A gene variants with listening to music

New findings disclose mechanisms that control Rb2/p130 gene expression in lung cancer cells

New study discloses mechanism controlling Rb2/p130 gene expression in lung cancer cells

Symposium examines Bruesewitz vs. Wyeth Supreme Court case

Evolutionary changes may have influenced metabolism and increased risk of diabetes

Research: Loss of CMAH's function may make humans more prone to obesity and diabetes

PolyMedix completes PMX-30063 Phase 1 exposure-escalation clinical study to treat Staph infections

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News